SIGNIFICANCE OF C3D BINDING DONOR SPECIFIC ANTIBODIES PERSISTING SHORT TERM AFTER KIDNEY TRANSPLANTATION

被引：0
|
作者：
Kang, Eun-Suk [1 ]
Choi, Soo In [1 ]
Kee, Kyo Won [1 ]
Park, Jae Berm [1 ]
Kim, Sung Joo [1 ]
Jang, Hye Ryon [1 ]
Huh, Wooseong [1 ]
Kim, Dae Joong [1 ]
Kim, Yoon Goo [1 ]
Oh, Ha-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
BOS333
引用
收藏
页码：262 / 262
页数：1
相关论文
共 50 条
  • [41] Frequency of Human Leukocyte Antigens and Donor Specific Antibodies in Long-Term Living Donor Kidney Transplantation
    Alagoz, Selma
    Seyahi, Nurhan
    TRANSPLANTATION PROCEEDINGS, 2019, 51 (07) : 2302 - 2307
  • [42] Intra-Liver Allograft C3d-Binding Donor-Specific Anti-HLA Antibodies Predict Rejection After Liver Transplantation
    Nakamura, Tsukasa
    Shirouzu, Takayuki
    Sugimoto, Ryusuke
    Harada, Shumpei
    Yoshikawa, Mikiko
    Nobori, Shuji
    Ushigome, Hidetaka
    Kawai, Shintaro
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (02) : 450 - 453
  • [43] STRENGTH/SPECIFICITY OF DE NOVO HLA DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANTATION: CLINICAL SIGNIFICANCE
    Piazza, Antonina
    Poggi, Elvira
    Ozzella, Giuseppina
    Adorno, Domenico
    HUMAN IMMUNOLOGY, 2009, 70 : S64 - S64
  • [44] Clinical utility of C3d binding donor-specific anti-human leukocyte antigen antibody detection by single antigen beads after kidney transplantationa retrospective study
    Pelletier, Ronald P.
    Balazs, Ivan
    Adams, Pat
    Rajab, Amer
    DiPaola, Nicholas R.
    Henry, Mitchell L.
    TRANSPLANT INTERNATIONAL, 2018, 31 (04) : 424 - 435
  • [45] Prognostic value of C3d-fixing, preformed donor-specific antibodies in crossmatch-positive living kidney transplantation
    Miyake, Katsunori
    Okumi, Masayoshi
    Kakuta, Yoichi
    Unagami, Kohei
    Furusawa, Miyuki
    Ishida, Hideki
    Tanabe, Kazunari
    TRANSPLANT IMMUNOLOGY, 2019, 57
  • [46] Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation
    Hourmant, M
    Cesbron-Gautier, A
    Terasaki, PI
    Mizutani, K
    Moreau, A
    Meurette, A
    Dantal, J
    Giral, M
    Blancho, G
    Cantarovich, D
    Karam, G
    Follea, G
    Soulillou, JP
    Bignon, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09): : 2804 - 2812
  • [47] IMPLICATION OF COMPLEMENT BINDING C3D HLA ANTIBODIES AND ANTI-MICA ANTIBODIES IN HAPLOIDENTICAL/MISMATCHED HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES
    Singh, Meenakshi
    Rajak, Jyoti
    Parthasarathy, Sreeja
    HLA, 2019, 93 (05) : 367 - 368
  • [48] The Prevalence and Clinical Significance of C1q Binding Donor-Specific Anti-HLA Antibodies in Patients With Functioning Allografts More Than 5 Years After Kidney Transplantation
    Calp-Inal, S.
    Colovai, A.
    Melamed, M.
    Masiakos, P.
    Turgut, D.
    Akalin, E.
    TRANSPLANTATION, 2014, 98 : 83 - 84
  • [49] DE NOVO DONOR SPECIFIC ANTIBODIES AFTER KIDNEY TRANSPLANTATION - OUR EXPERIENCE OF CLINICAL RELEVANCE
    Dukic, Tatjana M.
    Simonovic, Ruzica B.
    Andric, Zorana P.
    Dmitrovic, Jelena M.
    HLA, 2019, 93 (05) : 311 - 311
  • [50] DONOR SPECIFIC ANTI-HLA IGA ANTIBODIES AND GRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION
    Arnold, Marie-Luise
    Bach, Christian
    Heinemann, Falko M.
    Dick, Andrea
    Spriewald, Bernd M.
    HLA, 2018, 91 (05) : 358 - 358
12345